Patient Preference Information – Submission, Review in PMAs, HDE Applications, and De Novo Requests, and Inclusion in Device Labeling

1 organizations filed 3 public comments on Patient Preference Information – Submission, Review in PMAs, HDE Applications, and De Novo Requests, and Inclusion in Device Labeling, at the Food and Drug Administration. The comment window closed 600d ago.

Abstract

Draft Guidance for Industry, Food and Drug Administration Staff and Other Stakeholders; Availability

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  3 filings · confidence 97%